Hemophilia without prophylaxis: Assessment of joint range of

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A - Research and Practice in Thrombosis and Haemostasis

Hemophilia A and B: An Overview

The bleeding phenotype in people with nonsevere hemophilia - ScienceDirect

Bleeding Disorders 101 - Haemnet

Functional Independence Score in Hemophilia (FISH) - eLearning Platform

Full article: Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study

Hemophilia Review

Severe Hem A Patients Showing Bleeds, Physical Limits With Prophylaxis

Clinical outcome and incidence of inhibitor development in severe hemophilia patients receiving low-dose prophylaxis: a 3-year follow-up study in Senegal, West Africa

Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Women's Health and Education Center (WHEC) - Newborn Care - Hemophilia: A Comprehensive Review

Frontiers Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A

A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy